Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Rizvi, K.
Right arrow Articles by Harvey, J. N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rizvi, K.
Right arrow Articles by Harvey, J. N
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Family Practice Vol. 19, No. 1, 95-98
© Oxford University Press 2002

Systematic Review

Do lipid-lowering drugs cause erectile dysfunction? A systematic review

Kash Rizvi, John P Hampson and John N Harvey

University of Wales College of Medicine, Wrexham Academic Unit, Wrexham, UK.

Dr JN Harvey, Diabetes Unit, Gladstone Centre, Maelor Hospital, Wrexham LL13 7TD, UK.

Abstract

Background. Erectile dysfunction (ED) is common although under-reported by patients. Along with the better known causes of ED, drug-induced impotence needs to be considered as a cause of this symptom. Lipid-lowering drugs have been prescribed increasingly. Their relationship to ED is controversial.

Objectives. Our aim was to clarify the relationship between lipid-lowering therapy and ED. A secondary aim was to assess the value of the sytematic review procedure in the area of adverse drug reactions.

Methods. A systematic review was carried out using computerized biomedical databases and Internet sources. Terms denoting ED were linked with terms referring to lipid-lowering drugs. Information was also sought from regulatory agencies.

Results. A significant literature was identified, much from obscure sources, which included case reports, review articles, and information from clinical trials and from regulatory agencies. Information from all of these sources identified fibrates as a source of ED. A substantial number of cases of ED associated with statin usage have been reported to regulatory agencies. Case reports and clinical trial evidence supported the suggestion that statins can also cause ED. Some information on possible mechanisms was obtained, but the mechanism remains uncertain.

Conclusions. The systematic review procedure was applied successfully to collect evidence suggesting that both statins and fibrates may cause ED. More numerous reports to regulatory agencies complemented more detailed information from case reports to provide a new perspective on a common area of prescribing.

Keywords. Adverse drug reactions, erectile dysfunction, fibrates, statins.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
S. A Linnebur and W. H Hiatt
Probable Statin-Induced Testicular Pain
Ann. Pharmacother., January 1, 2007; 41(1): 138 - 142.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
U. Ravnskov, P. J Rosch, M. C Sutter, and M. C Houston
Should we lower cholesterol as much as possible?
BMJ, June 3, 2006; 332(7553): 1330 - 1332.
[Full Text] [PDF]

Home page
 Endocr. Rev.Home page
P. Y. Liu, A. K. Death, and D. J. Handelsman
Androgens and Cardiovascular Disease
Endocr. Rev., June 1, 2003; 24(3): 313 - 340.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
B. G.A. Stuckey, M. N. Jadzinsky, L. J. Murphy, F. Montorsi, A. Kadioglu, F. Fraige, P. Manzano, and C. Deerochanawong
Sildenafil Citrate for Treatment of Erectile Dysfunction in Men With Type 1 Diabetes: Results of a randomized controlled trial
Diabetes Care, February 1, 2003; 26(2): 279 - 284.
[Abstract] [Full Text] [PDF]

Home page
 Fam PractHome page
M. H Blanker and A. P Verhagen
Lipid-lowering drugs and erectile dysfunction
Fam. Pract., October 1, 2002; 19(5): 567 - 567.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.